| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0013 | 1 |